MEDICAMEQ

Medicamen Biotech Ltd, incorporated in 1993, operates as a research-led pharmaceutical company specializing in the development, manufacturing, and marketing of generic finished dosage formulations, including oncology formulations. The company’s business segments include generic pharmaceutical formulations, oncology formulations, and general pharmaceutical formulations. It serves both domestic and international markets, reaching over 35 countries worldwide, with a strategic emphasis on regulated markets and complex generics in the oncology therapeutic area. Medicamen Biotech Ltd is a subsidiary of Shivalik Rasayan Limited, which holds a 42.99% equity stake. The company is positioned within the pharmaceutical industry and continues to focus on expanding its presence in specialized areas of pharmaceuticals.